MedTrace Logo

Multi-Level Stigma Intervention for Mental Health Services

NCT06200012 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2025-10-14

No results posted yet for this study

Summary

This cluster randomized trial develops and pilot tests a multi-level substance use stigma intervention that leverages organizational policy and professional education to address structural and professional drivers of stigma in outpatient mental health (MH) services. The investigators will generate preliminary data to determine whether adding an organizational policy to a professional stigma training may reduce measures of provider-based stigma towards substance use and improve care quality and patient outcomes to a greater degree than simply conducting training alone. The investigators hypothesize that providers at a MH site implementing an organizational policy change in addition to providing professional training will demonstrate greater improvement to health services for people who use drugs compared to a site where providers receive training alone.

Conditions

Interventions

BEHAVIORAL

Multi-level stigma reduction intervention: educational training plus controlled substance agreement policy change

Pairing a professional training targeting known attitudinal and knowledge drivers of substance use stigma with a policy altering potentially stigmatizing features of controlled substance agreements.

BEHAVIORAL

Single-level stigma reduction intervention: educational training

A professional training targeting known attitudinal and knowledge drivers of substance use stigma

Sponsors & Collaborators

  • University of New Mexico

    collaborator OTHER

  • Loyola University Chicago

    collaborator OTHER

  • LifeStance Health

    collaborator UNKNOWN

  • Wayne State University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-11-06
Primary Completion
2024-02-08
Completion
2025-02-08

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06200012 on ClinicalTrials.gov